APA (7th ed.) Citation

VW, Z., AB, S., SM, A., & SI, O. (2019). Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification. Dove Medical Press.

Chicago Style (17th ed.) Citation

VW, Zhu, Schrock AB, Ali SM, and Ou SI. Differential Response to a Combination of Full-dose Osimertinib and Crizotinib in a Patient with EGFR-mutant Non-small Cell Lung Cancer and Emergent MET Amplification. Dove Medical Press, 2019.

MLA (8th ed.) Citation

VW, Zhu, et al. Differential Response to a Combination of Full-dose Osimertinib and Crizotinib in a Patient with EGFR-mutant Non-small Cell Lung Cancer and Emergent MET Amplification. Dove Medical Press, 2019.